Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
110.00    -3.00 (-2.65%)
Bid:
108.00
Ask:
112.00
Spread: 4.00 (3.704%)
Market Cap: £66.18m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Contract Orders and Renewals

8 Jan 2025 07:00

RNS Number : 4778S
Intercede Group PLC
08 January 2025
 

8 January 2025

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

Contract Orders and Renewals for MyID CMS and Maiden Order for MyID SecureVault

Intercede, the leading cybersecurity software company specialising in digital identities, is pleased to announce continued momentum in the business with further contract orders and renewals worth over $5m in aggregate being signed during the month of December 2024.

These include the following new orders and renewals:

 

· A major licence order MyID CMS from a systems integrator for a new government end client based in Asia. The order is for c$0.9m with associated multi-year support and maintenance of c$0.56m;

 

· For the same client above, the maiden subscription licence order for MyID SecureVault of c$0.5m over a 2-year period;

· A MyID MFA licence subscription order for a leading airline in the Middle East (new logo) through a new partner focussing on airport security screening;

· A MyID MFA licence subscription order for a leading Kuwaiti Bank (new logo) contracted through Intercede's distribution channel in the region; and

· MyID CMS subscription licence order for an American publicly traded, government sponsored enterprise (new logo), contracted through a managed services partner: and

· The following renewals for MyID CMS:

a support and maintenance renewal from a large US Federal Agency in excess of $1.4m;

a support and maintenance renewal from a large US Federal Agency in excess of $1.0m;

a support and maintenance renewal from a key US Federal Agency in excess of $0.15m.

In addition to the above licence orders and renewals, the Company also secured several professional services orders worth, in aggregate, c$0.4m to implement new installations and provide ongoing customer support.

 

These orders, combined with expected additional conversion of the existing pipeline in Q4 FY25, means that the Company now expects financial performance to be ahead of market expectations for FY25* and further underpins confidence looking forward towards FY26 and FY27.

 

Klaas van der Leest, CEO, commented:

 

"We are very pleased to secure new licence orders in the Rest of the World territory (excluding Americas), especially with a new government end client based in Asia which also includes the first subscription licence order for MyID SecureVault.

 

The orders were contracted through Asia's leading cyber security services provider, and once again, underpins our go-to-market strategy.

 

The Group continues to demonstrate its ability to address client needs quickly, efficiently, and commercially as the maiden order for MyID SecureVault shows.

The renewals and services highlight the critical nature of our software once in production and underpins the long tenure of our existing client base".

 

* The Board believes that the current consensus estimates for the year ending 31 March 2025 is revenue of £16.1 million and adjusted EBITDA of £3.3 million.

 

ENQUIRIES

Intercede Group plc

Tel. + 44 (0)1455 558111

Klaas van der Leest

CEO

Nitil Patel

CFO

 

 

 

Cavendish Capital Markets Limited

Tel. + 44 (0)20 7220 0500

Marc Milmo/Fergus Sullivan/Rory Sale

Corporate Finance

Tim Redfern/Ondraya Swanson

ECM

 

About Intercede

Intercede is a cybersecurity software company specialising in digital identities, and its innovative solutions enable organisations to protect themselves against the number one cause of data breach: compromised user credentials.

 

The Intercede suite of products allows customers to choose the level of security that best fits their needs, from Secure Registration and ID Verification to Password Security Management, One-Time Passwords, FIDO and PKI. Uniquely, Intercede provides the entire set of authentication options from Passwords to PKI, supporting customers on their journey to passwordless and stronger authentication environments. In addition to developing and supporting Intercede software, the Group offers professional services and custom development capabilities as well as managing the world's largest password breach database.

 

For over 20 years, global customers in government, aerospace and defence, financial services, healthcare, telecommunications, cloud services and information technology have trusted Intercede solutions and expertise in protecting their mission critical data and systems at the highest level of assurance.

For more information visit: www.intercede.com

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTDZGGMNNDGKZM
Date   Source Headline
20th Jul 20217:00 amRNSIntercede achieves FIDO2 certification
5th Jul 20217:00 amRNSConnect Partner Programme & Q1 Contract Wins
15th Jun 20218:26 amRNSIssue of Equity
8th Jun 20217:00 amRNSFinal Results
2nd Jun 202110:09 amRNSInvestor Presentation
10th May 20217:00 amRNSShare Incentive Plan
7th Apr 20217:00 amRNSTrading Update & Appointment of Auditor
1st Apr 202110:30 amRNSReceipt of $3.4m Order
10th Mar 20217:00 amRNSShare Incentive Plan
23rd Feb 20217:00 amRNSAmendment to LTIP
22nd Feb 20214:10 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSCLN Conversion to Equity
12th Feb 20217:00 amRNSHolding(s) in Company
8th Feb 202112:40 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSCLN Call & Issue of Equity
11th Jan 20217:00 amRNSNew Contract Win
5th Jan 202111:00 amRNSCLN Conversion to Equity
4th Jan 202110:40 amRNSHolding(s) in Company
22nd Dec 20207:00 amRNSNew Contract Win
24th Nov 20207:00 amRNSHalf-year Report
17th Nov 20207:00 amRNSContract Win: Follow-on Purchase Order
12th Nov 20207:00 amRNSInvestor Presentation
8th Oct 20207:01 amRNSIntercede join the FIDO Alliance
8th Oct 20207:00 amRNSTrading Update
16th Sep 20203:40 pmRNSResult of AGM
20th Aug 20207:05 amRNSContract Win - Initial Progress Order
5th Aug 20202:01 pmRNSHolding(s) in Company
30th Jul 20207:00 amRNSContract Win
2nd Jun 20207:00 amRNSFinal Results
12th May 20207:00 amRNSShare Incentive Plan
20th Apr 202010:02 amRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSTrading Update
3rd Apr 20205:07 pmRNSShare Incentive Plan
31st Mar 20207:00 amRNSReceipt of $4.6m Order
28th Feb 20207:00 amRNSShare Incentive Plan
26th Feb 20209:50 amRNSShare Incentive Plan
25th Feb 20207:00 amRNSShare Incentive Plan
12th Feb 202011:22 amRNSShare Award
25th Nov 20197:00 amRNSHalf-year Report
7th Oct 20197:00 amRNSTrading Update
30th Sep 20197:00 amRNSDirector/PDMR Shareholding
18th Sep 20196:30 pmRNSResult of AGM
16th Sep 20193:56 pmRNSPosting of Annual Report & Notice of AGM
17th Jun 20197:00 amRNSAppointment of Non-Executive Director
5th Jun 20197:00 amRNSFinal Results
8th Apr 20197:00 amRNSSale of Property
2nd Apr 20197:00 amRNSTrading Update
28th Feb 20197:00 amRNSNew Contract Win
4th Feb 20193:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.